SymbolMNKD
NameMANNKIND CORP
SectorHEALTH CARE
RegionNorth America
IndustryPharmaceutical Preparations
Address1 CASPER STREET, DANBURY, CT 06810
Telephone818-661-5000
Fax
Email
Websitehttps://www.mannkindcorp.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0000899460
Description

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Additional info from NASDAQ:
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

2026-05-14 17:51

New Form 144/A - MANNKIND CORP <b>Filed:</b> 2026-05-14 <b>AccNo:</b> 0001950047-26-004547 <b>Size:</b> 4 KB

Read more
2026-05-14 00:30

Tross Stuart A 🔴 sold 8.1K shares of MANNKIND CORP (MNKD) at $3.52 Transaction Date: May 11, 2026 | Filing ID: 222312

Read more
2026-05-14 00:30

Binder Steven B. 🔴 sold 22.5K shares of MANNKIND CORP (MNKD) at $3.52 Transaction Date: May 11, 2026 | Filing ID: 222311

Read more
2026-05-14 00:30

Castagna Michael 🔴 sold 35.0K shares of MANNKIND CORP (MNKD) at $3.52 Transaction Date: May 11, 2026 | Filing ID: 222309

Read more
2026-05-14 00:30

Thomson David 🔴 sold 15.4K shares of MANNKIND CORP (MNKD) at $3.52 Transaction Date: May 11, 2026 | Filing ID: 222310

Read more
2026-05-12 20:34

📋 DAVID THOMSON (Officer) plans to sell 10K shares of MannKind Corporation (at $3.36 each, total $34K) Filed: May 12, 2026 | ID: 004413

Read more
2026-05-12 20:34

📋 STEVEN BINDER (Director) plans to sell 17K shares of MannKind Corporation (at $3.36 each, total $57K) Filed: May 12, 2026 | ID: 004412

Read more
2026-05-12 12:29

New Form SCHEDULE 13G - MANNKIND CORP <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0000093751-26-000262 <b>Size:</b> 8 KB

Read more
2026-05-08 22:20

New Form 4/A - MANNKIND CORP <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001193125-26-215284 <b>Size:</b> 4 KB

Read more
2026-05-06 20:03

(10% Negative) MANNKIND CORP (MNKD) Reports Q2 2026 Financial Results

Read more